[{"address1": "2 Bloor Street West", "address2": "Suite 903 7th Floor", "city": "Toronto", "state": "ON", "zip": "M4W 3E2", "country": "Canada", "phone": "416 648 5555", "website": "https://www.medicenna.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Fahar  Merchant Ph.D.", "age": 67, "title": "Founder, Chairman, President & CEO", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 554091, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rosemina  Merchant B.Sc., M.E.Sc", "age": 67, "title": "Founder & Chief Development Officer", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 358410, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Hyman CA, CBV", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 87098, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel R. Denmeade M.D.", "title": "Scientific Advisor", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.87, "open": 0.852, "dayLow": 0.8, "dayHigh": 0.852, "regularMarketPreviousClose": 0.87, "regularMarketOpen": 0.852, "regularMarketDayLow": 0.8, "regularMarketDayHigh": 0.852, "payoutRatio": 0.0, "beta": 1.877, "forwardPE": -4.7058825, "volume": 26542, "regularMarketVolume": 26542, "averageVolume": 100790, "averageVolume10days": 225100, "averageDailyVolume10Day": 225100, "bid": 0.7951, "ask": 0.8199, "bidSize": 29800, "askSize": 3600, "marketCap": 66729148, "fiftyTwoWeekLow": 0.573, "fiftyTwoWeekHigh": 1.43, "allTimeHigh": 6.84, "allTimeLow": 0.151, "fiftyDayAverage": 0.93834, "twoHundredDayAverage": 0.76712, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 51130148, "profitMargins": 0.0, "floatShares": 60775240, "sharesOutstanding": 83411435, "sharesShort": 109389, "sharesShortPriorMonth": 278169, "sharesShortPreviousMonthDate": 1694736000, "dateShortInterest": 1697155200, "sharesPercentSharesOut": 0.0016, "heldPercentInsiders": 0.20822, "heldPercentInstitutions": 0.06317, "shortRatio": 0.77, "shortPercentOfFloat": 0.0069999998, "impliedSharesOutstanding": 83411435, "bookValue": 0.08927586, "priceToBook": 8.960989, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13815000, "trailingEps": -0.12, "forwardEps": -0.17, "enterpriseToEbitda": -2.346, "52WeekChange": -0.28333336, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 0.8, "targetHighPrice": 4.0, "targetLowPrice": 2.5, "targetMeanPrice": 3.25, "targetMedianPrice": 3.25, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 15748000, "totalCashPerShare": 0.189, "ebitda": -21798000, "totalDebt": 149000, "quickRatio": 3.815, "currentRatio": 4.008, "debtToEquity": 1.455, "returnOnAssets": -0.53507, "returnOnEquity": -0.91206, "freeCashflow": -9880250, "operatingCashflow": -17034000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "MDNAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Medicenna Therapeutics Corp.", "regularMarketChangePercent": -8.045976, "regularMarketPrice": 0.8, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1765572114, "exchange": "OQX", "messageBoardId": "finmb_245978917", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChange": -0.06999999, "regularMarketDayRange": "0.8 - 0.852", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 100790, "fiftyTwoWeekLowChange": 0.227, "fiftyTwoWeekLowChangePercent": 0.39616054, "fiftyTwoWeekRange": "0.573 - 1.43", "fiftyTwoWeekHighChange": -0.62999994, "fiftyTwoWeekHighChangePercent": -0.44055942, "fiftyTwoWeekChangePercent": -28.333336, "earningsTimestampStart": 1770930000, "earningsTimestampEnd": 1770930000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.12, "epsForward": -0.17, "fiftyDayAverageChange": -0.13834, "fiftyDayAverageChangePercent": -0.14743057, "twoHundredDayAverageChange": 0.03288001, "twoHundredDayAverageChangePercent": 0.04286162, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1510583400000, "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]